Breakthrough Cancer Pain

MoA video for a U.S. product launch of a breakthrough oncology drug.

This 3D mechanism-of-action animation has been created for the U.S. product launch of Abstral® (fentanyl) Sublingual Tablets, the treatment for Breakthrough Cancer Pain (BTcP).

We began the video with the introduction of the cause of pain; highlighting metastatic bone cancer, before showcasing the mechanism of action (MOA) of the drug and its significant effect on breakthrough cancer pain.

Deliverables

3D animation, product shots, high resolution images

Brand

Abstral®

Client

Galena Biopharma

3D product shot for cancer pain, illustrated by Geometric Medical
Breakthrough Cancer Pain Animation
Cancer Pain Animation
Breakthrough Cancer Pain Animation by Geometric Medical

What is Breakthrough Cancer Pain

Breakthrough cancer pain (BTcP) is defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.

Breakthrough cancer pain occurs in the majority of patients who are already receiving chronic, long-acting opioid pain management and yet have episodes of severe tumor- and treatment-related cancer pain.

reference: galenabiopharma.com

Metastatic bone cancer, illustrated and animated by Geometric Medical

The video is fantastic! It looks great! We appreciate the effort to get this in time for our conference.

Director, Oncology Marketing, Galena Biopharma, Oregon, USA

Related Work

Need help with a project?

Get in touch and start your creative journey.

Contact Us

Next case study

New Business

info@geometricmedical.com

+44 (0) 20 7183 9412 - UK

+1 646 568 4358 - USA

Studio

35A Victoria Rd.,
Surbiton, Surrey,
KT6 4JT, UK